With Amantide, the price does NOT vary according to the number of follicles transplanted. Generally, yes, the greater the number of follicles needed, the higher the cost may be. Amantide has chosen not to consider the number of follicles as a variable, for clinical, ethical, and management issues and to offer the best possible service without limits. The choice of the number of grafts to transplant is a clinical matter, a number necessary to achieve the optimal and desired outcome. It should not be a potential patient choice driven by the financial issue (“if I get the necessary minimum number of folicoli transplanted, it costs less…” ) If during the process of analysis the clinician finds it necessary to change the number of folicles, having eliminated the number of folicles as an economic variable, the clinician can safely proceed with the appropriate solution for the case and the patient can achieve the best possible outcome with confidence, without additional costs. For these reasons, we definitely do not want such an important factor in the success of the transplant and the desired outcome to be influenced by economic choices.